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ABSTRACT
The plasma concentrations of granzymes are
considered to reﬂect the involvement of cytotoxic
T-cells and natural killer cells in various disease
states. Interferon (IFN)-c-inducible protein-10 (IP-
10) and monokine induced by IFN-c (Mig) are
members of the non-ELR CXC chemokine family
that act on T-cells and natural killer cells. This
study revealed that the plasma concentrations of
granzyme B (but not granzyme A), IP-10 and Mig
were higher in 44 Thai patients with deﬁnite or
possible leptospirosis than in healthy blood
donors. These data suggest that activation of
cell-mediated immunity is part of the early host
response to leptospirosis.
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Original Submission: 1 June 2006; Revised Submis-
sion: 24 August 2006; Accepted: 21 September 2006
Clin Microbiol Infect 2007; 13: 433–436
10.1111/j.1469-0691.2006.01640.x
Leptospirosis is caused by pathogenic spirochaetes
of the genus Leptospira, and is probably the world’s
most widespread zoonosis [1]. Cytotoxic T-cells
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and natural killer cells are the effector cells of cell-
mediated immunity, collectively referred to as
cytotoxic lymphocytes (CLs). CLs protect the host
by lysing cells infected by viruses, intracellular
bacteria or parasites [2]. Granzymes (Gr) are relea-
sed during degranulation of CLs, and increased
concentrations of soluble Gr are considered to
reﬂect the involvement of cytotoxic T-cells and
natural killer cells in various disease states [3].
Interferon-c-inducibleprotein-10(IP-10)andmono-
kine induced by interferon-c (Mig) are members of
the non-ELR CXC chemokine family that share a
common receptor, CXCR3,which is expressed only
on natural killer cells and T-lymphocytes [4].
The present study sought to obtain a ﬁrst insight
into activation of CLs during leptospirosis.
The study formed part of a larger study of acute
febrile illness in Udon Thani, Thailand [5,6].
EDTA-anticoagulated blood was collected from
consecutive patients upon admission for acute
febrile illness at Soon Udon Thani Hospital, Udon,
northern Thailand. A diagnosis of deﬁnite lepto-
spirosis (n = 28) was based on a positive blood
culture for leptospira, or a four-fold rise in titre, or
a single titre of >1:400, in the Microscopic Agglu-
tination Test (MAT; NIH, Bangkok, Thailand) or
the Indirect Immunoﬂuorescence Test (IFA-IgM;
NIH). A diagnosis of possible leptospirosis
(n = 16) was made when a patient did not fulﬁl
the above strict criteria, but had clinical symptoms
compatible with the disease and a positive result
with three or more of the following serological
screening tests: Lepto Tek Lateral Flow (Organon
Teknica, Boxtel, The Netherlands); Microscopic
Capsular Agglutination Test (Japan Lyophiliza-
tion Company, Tokyo, Japan); IgG ⁄ IgM ELISA
(Panbio, Brisbane, Australia); Latex Agglutination
Test (NIH); Dip-S-Tick Test (Panbio); or Multi-test
(Panbio). Blood was also collected from 50 anony-
mous healthy blood donors from the same area.
Informed consent was obtained from all patients.
All mediators were measured by ELISA (GrA and
GrB, Central Laboratory of the Netherlands Red
Cross Blood Transfusion Service, Amsterdam, The
Netherlands; IP-10, R&D Systems, Abingdon, UK;
Mig, Pharmingen, San Diego, CA, USA), with
detection limits of 4.1, 3.3, 204.8 and 82.3 pg ⁄mL,
respectively. Values are given as medians and
ranges. Differences between controls and patient
groups were analysed by the Mann–Whitney U-
test, with p <0.05 considered to be statistically
signiﬁcant. Spearman’s q was used to analyse
correlations among variables.
Patient characteristics are summarised in
Table 1 (healthy blood donors remained anony-
mous). The plasma concentrations measured are
shown in Fig. 1. GrA levels were signiﬁcantly
higher among controls (41.2, range £4.1–256.7,
pg ⁄mL) than among patients with deﬁnite lepto-
spirosis (19.9, range £4.1–102.8, pg ⁄mL, p 0.005) or
possible leptospirosis (13.1, range £4.1–4487,
pg ⁄mL, p 0.028). GrB levels were lower among
controls (3.3, range £3.3–153.0, pg ⁄mL) than
among patients with deﬁnite leptospirosis (28.7,
range £3.3–191.6, pg ⁄mL, p <0.0001) or possible
leptospirosis (43.8, range 7.9–4590, pg ⁄mL,
p <0.0001). Gr levels did not differ among leptos-
pirosis patients with and without positive blood
cultures (data not shown). There was no correla-
tion between GrA and GrB levels in any of the
groups. IP-10 was detectable in only two of the
healthy donors (range £204.8–1648 pg ⁄mL). Plas-
ma IP-10 levels among patients with deﬁnite
leptospirosis (637.9, range £204.8–25 994, pg ⁄mL,
p <0.0001) and patients with possible leptospirosis
(1068, range £204.8–7783, pg ⁄mL, p 0.0003) were
higher than among controls. Mig was detectable in
plasma in only one (2%) (range £82.3–332 pg ⁄mL)
of the controls, in 15 (54%) patients with deﬁnite
leptospirosis (374.2, range £82.3–20 621, pg ⁄mL)
and in four (25%) patients with possible leptos-
pirosis (82.3, range £82.3–24 987, pg ⁄mL). Mig
levels were higher among patients with deﬁnite
leptospirosis than among controls (p <0.0001). In
patientswith deﬁnite or possible leptospirosis,Mig
correlated positivelywith IP-10 (q 0.60; p <0.0001).
There were no differences in the concentrations of
these mediators among patients with and without
positive blood cultures (data not shown).
Table 1. Patient characteristics upon admissiona
Deﬁnite leptospirosis
n = 28
Possible leptospirosis
n = 16
Age (years) 38 (15–63) 34 (15–51)
Gender (male ⁄ female) 18 ⁄ 10 13 ⁄ 3
Duration of symptoms (days) 4 (2–10) 5 (2–8)
Systolic blood pressure (mm Hg) 01 (74–165) 100 (50–139)
Temperature (C) 38.2 (37.2–40.4) 38.6 (37.1–42.5)
Serum urea (mg ⁄dL) 22 (8–102) 22 (4–110)
Serum creatinine (mg ⁄dL) 1.5 (0.7–10.8) 1.2 (0.7–7.1)
Total serum bilirubin (mg ⁄dL) 1.4 (0.3–23.2) 1.9 (0.4–24.5)
Direct serum bilrubin (mg ⁄dL) 0.7 (0.1–14.2) 1.3 (0.1–11.9)
Haemoglobin (g ⁄dL) 12.2 (7.0–16.1) 12.1 (7.3–14.3)
White blood cells · 109 ⁄L 10.7 (4.7–32.6) 11.5 (4.3–44.0)
% Neutrophils 87 (45–96) 87 (62–95)
% Lymphocytes 9.5 (1–41) 10 (4–35)
aValues are given as medians and ranges. For deﬁnitions of deﬁnite and possible
leptospirosis, see Materials and Methods. There were no signiﬁcant differences in
any of the parameters between the two groups.
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Host defence against extracellular organisms is
predominantly humoral in nature, whereas intra-
cellular organisms are contained by a cellular
immune response [7]. Since leptospires are extra-
cellular organisms, a humoral immune response
has been considered previously to contribute
most to host defence against this pathogen [8].
The present study investigated the role of cell-
mediated immunity in response to infection with
Leptospira by studying the activation of CLs.
Previous studies have documented elevated lev-
els of Gr among patients with viral infections,
scrub typhus and melioidosis [6,9–11]. Gram-
positive and Gram-negative bacteria can induce
the secretion of Gr in vitro [11]. In the present
study, GrB levels were found to be elevated
among patients with deﬁnite or possible leptospi-
rosis. Surprisingly, GrA levels were lower in both
patient groups compared with controls, which
contrasts with earlier ﬁndings for scrub typhus
and melioidosis [6,11]. In addition, GrA and GrB
levels did not show a correlation. Together, these
data suggest that the release of GrA and GrB is
regulated by different mechanisms, and that
leptospirosis does not trigger GrA release.
IP-10 and Mig, two chemokines that are
induced in response to interferon-c, bind specif-
ically to CXCR3 [4]. It has been suggested that
enhanced production of IP-10 and Mig may be
important for the activation and attraction of
CXCR3+ T-helper 1 cells to the site of infection,
which can contribute to host defence by the
production of additional type 1 cytokines. In
particular, expression of IP-10 and ⁄ or Mig has
been found among patients suffering from dis-
eases associated with a type 1 immune response,
including leishmaniasis, tuberculosis, tuberculoid
leprosy, Chlamydia infections, and scrub typhus
[6,12–14]. The present ﬁndings indicate that
increased production of these mediators of a
Fig. 1. Plasma concentrations of granzyme A, granzyme B, interferon (IFN)-c-inducible protein 10 (IP-10) and monokine
induced by IFN-c (Mig) in patients with deﬁnite (def) or possible (poss) leptospirosis (for deﬁnitions see Materials and
Methods), and healthy blood donors. Horizontal lines represent medians; dotted lines represent detection limits of the
assays. The p values reﬂect differences between patient groups according to the Mann–Whitney U-test.
Research Notes 435
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 430–456
cellular immune response is not limited to
intracellular infections. In agreement with these
results, a number of Gram-negative and Gram-
positive bacteria are capable of inducing IP-10 and
Mig release in human whole blood in vitro [15].
To our knowledge, this is the ﬁrst study in
which the circulating levels of GrA, GrB, IP-10
and Mig have been studied in a large series of
patients with leptospirosis. The observation of
elevated levels of GrB, IP-10 and Mig in these
patients suggests that activation of a cellular
immune response is part of the early host defence
against Leptospira.
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ABSTRACT
This ad-hoc observational study, conducted in the
metropolitan area of Berlin during 2004, revealed
that the prevalence of Chlamydia trachomatis (CT)
infections in female urban adolescents self-pre-
senting at their gynaecologist without (n = 397) or
with (n = 124) symptoms of CT infection was
5.5% (95% CI 3.7–8.2%) and 9.7% (95% CI 5.6–
16.2%), respectively. The prevalence of CT infec-
tion was signiﬁcantly dependent on the number
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